Douglas F. Kling
Overview
Douglas F. Kling received an average of $371K in total compensation, including $218K in salary, at Matinas BioPharma Holdings between 2015 and 2016.
Source: SEC filing on September 14, 2017.
Related executives
We found nine more executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings